Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.
Saved in:
| Title: | Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. |
|---|---|
| Authors: | Perdrizet J; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA., Santana CFS; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Senna T; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Alexandre RF; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Sini de Almeida R; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil., Spinardi J; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil., Wasserman M; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Apr 03; Vol. 17 (4), pp. 1162-1172. Date of Electronic Publication: 2020 Sep 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2164-554X |
|---|---|
| DOI: | 10.1080/21645515.2020.1809266 |
